Cargando…
In vitro and in vivo antitumor effect of gefitinib nanoparticles on human lung cancer
Gefitinib (GEF) is the first epidermal growth factor receptor (EGFR)-targeting agent launched as an anticancer drug. It is an accepted opinion that modifying GEF strong hydrophobicity and poor bioavailability would not only enhance its antitumor effects, but also reduce its side effects. In this stu...
Autores principales: | Ni, Xiao Ling, Chen, Long Xia, Zhang, Heng, Yang, Bo, Xu, Shan, Wu, Min, Liu, Jing, Yang, Ling Lin, Chen, Yue, Fu, Shao Zhi, Wu, Jing Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241075/ https://www.ncbi.nlm.nih.gov/pubmed/28961023 http://dx.doi.org/10.1080/10717544.2017.1384862 |
Ejemplares similares
-
Preparation, characterization, in vitro and in vivo anti-tumor effect of thalidomide nanoparticles on lung cancer
por: Chen, Long Xia, et al.
Publicado: (2018) -
Honokiol-loaded polymeric nanoparticles: an active targeting drug delivery system for the treatment of nasopharyngeal carcinoma
por: Yang, Bo, et al.
Publicado: (2017) -
In vivo antitumor effect of endostatin-loaded chitosan nanoparticles combined with paclitaxel on Lewis lung carcinoma
por: Xie, Fang, et al.
Publicado: (2017) -
In vivo synergistic anti-tumor effect of paclitaxel nanoparticles combined with radiotherapy on human cervical carcinoma
por: Yu, YanXin, et al.
Publicado: (2017) -
Preparation of endostatin-loaded chitosan nanoparticles and evaluation of the antitumor effect of such nanoparticles on the Lewis lung cancer model
por: Ding, Rui-Lin, et al.
Publicado: (2017)